Alverbratt, C. (2025) “Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study”, Acta Oncologica, 64, pp. 1391–1403. doi: 10.2340/1651-226X.2025.43794.